↓ Skip to main content

Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison

Overview of attention for article published in Experimental Hematology & Oncology, December 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#41 of 296)
  • Good Attention Score compared to outputs of the same age (79th percentile)

Mentioned by

policy
2 policy sources

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison
Published in
Experimental Hematology & Oncology, December 2013
DOI 10.1186/2162-3619-2-32
Pubmed ID
Authors

James Signorovitch, Elyse Swallow, Evan Kantor, Xufang Wang, Judith Klimovsky, Tomas Haas, Beth Devine, Peter Metrakos

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Brazil 1 3%
Unknown 38 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 23%
Student > Ph. D. Student 6 15%
Student > Bachelor 5 13%
Other 4 10%
Professor 3 8%
Other 6 15%
Unknown 7 18%
Readers by discipline Count As %
Medicine and Dentistry 18 45%
Biochemistry, Genetics and Molecular Biology 4 10%
Economics, Econometrics and Finance 3 8%
Business, Management and Accounting 1 3%
Computer Science 1 3%
Other 3 8%
Unknown 10 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#4,736,890
of 22,953,506 outputs
Outputs from Experimental Hematology & Oncology
#41
of 296 outputs
Outputs of similar age
#56,917
of 307,669 outputs
Outputs of similar age from Experimental Hematology & Oncology
#2
of 4 outputs
Altmetric has tracked 22,953,506 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 296 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,669 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.